Objective: To observe the effect of microencapsulated hepatocytes after intraperitoneal transplantation of hepatolenticular degeneration (HDL) of model rats' serum copper and copper metabolism in liver. Methods: Rat HLD model was made by copper load diet. To prepare microencapsulated hepatocytes by the airflow method, and the method of intraperitoneal transplantation were used with naked cells or the microencapsulated cell transplantation, respectively, compared with blank control group group I), model group(group II), Bare hepatocytes after intraperitoneal transplantation group (group III) and microencapsulated hepatocyte transplantation group(group IV). Determination of HLD rat model of ALT, AST, albumin levels, copper of liver tissue, copper level in serum.
INTRODUCTION
Hepatolenticular degeneration (HLD) is a genetic disease with copper metabolic disorder characterized by multiple organ involvement, occur in adolescents, often early involvement of liver (1) , which is relatively common in China (2) . Hepatocyte transplantation has been becoming one of the treatment scheme of HLD (3, 4) .
Hepatocyte microencapsulation technology enables allogeneic cell transplantation becomes possible, which can effectively avoid immune rejection and prolong the lifespan of liver cells (5, 6) . In this artical, to study its effect on copper metabolism of HLD rats through the comparison of HLD microencapsulated rat hepatocytes after intraperitoneal transplantation and naked hepatocyte transplantation.
Materials and methods
Materials: Trypsin, Type I collagenase, EGTA, Sodium alginate, Poly lysine, Percoll(Sigma company, USA), DMEM culture medium (glucose, Hyclone company, USA), EDTA(Amresco company, USA), Trypan blue(Beijing Suolaibao company).
Isolation and culture of primary rat hepatocytes Liver tissue from adult male Wistar rats (provided by the experimental animal center of Wenzhou Medical University, approved by the ethics committee of Wenzhou medical university), hepatocyte isolated by EDTA-collagenase in situ two steps perfusion method (7) , The method is as follows: Rats were anesthetized, with D-Hank's solution for portacaval bypass perfusion, perfusion of about 30ml/min, about 7 minutes, waiting for the liver was soft opened, vena cava cannula outflow liquid turbid, stop infusion. Remove the liver, in DMEM medium to tear the liver capsule, hepatic cells gently shake off into the medium, followed by repeated centrifugation washing 2 times, liquid into cell suspension cultured with DMEM, Percoll separation of liquid specific gravity 1.096 purified hepatocytes. Obtained cell contained by DMEM complete culture medium of 10% fetal bovine serum and 1% penicillin streptomycin, cell counted and determined the activity after dyeing 4% trypan blue, each rat hepatocyte yield can reach more than 10 8 cells, when the cell activity of >85% preparing for microencapsulation.
Cell Microencapsulation
The preparation of microcapsules use of one-step process microcapsule-forming method with sodium alginate barium chloride (8) . Centrifugal collection of hepatocytes, and mixed 1.5% purified sodium alginate solution into the air-flow method, microcapsule generator homemade, gas flow rate of 4L/min, sodium alginate solution drop speed is 50ml/h, drip into the 25mmol/L BaCl 2 solution. Sodium alginate and Ba 2 ＋ cross-linked into capsules, and static 15min. Washed by D-Hanks liquid for 3 times to remove the excess BaCl 2 , into DMEM culture medium for culturing.
Establishment and experimental grouping of rat HLD model
Rat HLD model was established by copper loading method (9) . Took 120 male Wistar rats of 3 months old, according to the requirements of the experiment were randomly divided into model group (II group), bare hepatocytes after intraperitoneal transplantation group (group III) and microencapsulated hepatocyte transplantation group (group IV), divided into 5 time points with 3 days, 7 days, 14 days, 21 days, 28 days (copper load for ninth weeks as starting 0 days), each group 8 rats for per time point, another 8 rats as the blank control group (group I). All rats were fed for 12 weeks according to the standard, group II, group III and group IV were fed with feed containing copper sulfate 1g/kg and 0.185% copper sulfate water also, a total of 12 weeks. From ninth weeks of feeding, took the rat median abdominal incision 5mm, group II, group III and group IV according to the experimental requirements were respectively injected 0.9% sodium chloride solution 2ml, bare hepatocytes and hepatic cell microcapsules, with 12 gauge needle. Each rat of group III and group IV was peritoneal injected with approximately 1×10 7 liver cells. After operation strict disinfection of wounds was made.
Index Determination
ALT, AST, albumin determination were taken at different time points: the serum samples of Wistar rats, the value of ALT, AST, albumin was determined by automatic biochemical analyzer.
Determination of the content of serum copper: serum copper to be detected to measure serum 1:10 diluted with deionized water mixing, with atomic absorption spectrophotometry measurement. Liver tissue copper determination: first with 0.9% saline repeatedly washed out of the liver tissue, then clean and dry with filter paper and weighed 500mg, concentrated nitric acid (analytical) 10ml with low temperature heating digestion, and completely dissolved to yellow clear transparent, the determination of copper content by atomic absorption spectrometry.
The Statistical Method
Data processing and statistical analysis using SPSS 16 statistical software package, samples compared with single factor analysis of variance and Newman-Keuls test. When 7d group IV rats of ALT , AST level was significantly lower than that in group III (P<0.05), the lowest in 21d, were 85.1 + 7 U/L, 87.9 + 22.7 U/L, and albumin levels increased obviously, reached the highest to 38.36 + 1.52g/L in 21d also, but compared with group I, which still significant differences (P<0.05). (Figure 3 Serum copper in group IV in 3d higher than that in group III (P<0.05), but after 7d were all lower than group III (each P<0.05), the minimum to 2.44 + 0.18μg/ml, but still significantly higher than those in group I (P<0.05). Liver copper content of group IV in 3d, 7d compared with group III showed no difference (each P>0.05), but the 14d decreased (P<0.05), the minimum to 26.73 + 3.22μg/g, were significantly higher than that of group I (P<0.05) . (Figure 6 14d and 28d lower than that of group II (each P<0.05). Liver copper content of group IV in 3d, 7d compared with group III showed no difference (each P>0.05), but the 14d decreased (P<0.05).
Results
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Conclusion
Hepatolenticular degeneration (HLD) also known as Wilson disease, is a genetic disorder of copper metabolism caused by cirrhosis and in basal ganglia brain degeneration mainly autosomal recessive inherited disease (10, 11) . Children stage mainly shows liver damage, may display for the liver functional damage, cirrhosis, liver failure and so on, are the main diseases of childhood cirrhosis (12) . Surgical treatment especially in liver transplantation, HLD becomes one of metabolic diseases can be cured (13, 14) . However, due to the difficulty of the operation and the limitation of donor liver source, living liver transplantation can not carry out extensive.
Hepatocyte transplantation is a kind of transitional replacement therapy of orthotopic liver transplantation (OLT) , because of wide cell source (such as pig), and transplantation path feasibility, also can reconstruct the copper metabolism balance in the body, reverse HLD process (15) . But no matter what the liver and liver cells in vivo transplantation, immune rejection is the most important factors which still affecting the development of transplantation technology problem (16, 17) . In recent years developed microencapsulated hepatocytes technology with immune isolation barrier effectively, the research on cell transplantation has been paid more and more attention. Microencapsulated hepatocyte technology means hepatocyte is wrapped or isolated with selective semipermeable membrane (18) , cells need to survive nutrients, oxygen, metabolites and secretion of bioactive substances through a semipermeable membrane access, but host immune cells, immune globulin and complement can not through a semipermeable membrane, so hepatocyte in capsule will not suffer from host immune rejection and get long-term survival, exerts its biological function, to achieve the purpose of treatment. At present in the treatment of fulminant hepatic failure have got a high embodiment of value (19, 20) . The current HLD treatment has formed the hepatocyte transplantation in spleen transplantation method as the main pathway (21) . But cause of the size which restricted to microencapsulated hepatocytes (300 microns), spleen transplantation is obviously difficult to achieve, therefore this research selected peritoneal transplant operation-the most common pathway for microencapsulated transplantation.
Copper load model is currently the most common HLD animal model, can better reflect the similar HLD liver copper injury (22) . In this study, high concentrations of copper fed rats for up to 12 weeks in the given, the serum levels of ALT, AST and albumin levels showed a similar hepatitis even liver dysfunction performance, which is consistent with the liver damage after HLD copper deposition (23) . Liver copper and serum copper level is the direct reflection of liver copper deposition to lead liver damage extent, meanwhile, monitoring of copper level in liver tissue and serum helps to understand the effect of hepatocyte transplantation therapy. In this experiment, the treatment group (naked hepatocyte transplantation group and microencapsulated hepatocyte transplantation group) liver aminopherase levels in rats after transplantation than copper loaded rats have decreased, liver copper and serum copper levels also decreased, and the liver synthesis of albumin levels have also been enhanced. However, the naked hepatocyte transplantation group whether liver aminopherases, liver copper and serum copper level was decreased, or albumin synthesis recovery degree, or the effect of the consolidation time, compared microencapsulated hepatocyte transplantation group to the existence of significant differences. This may be due to immune bare hepatocytes can not tolerate receptor rejection. In this study, the decreasing degree of naked hepatocyte transplantation group liver aminopherase levels, copper levels were lowest in about 7 days, and 14 days is obviously aggravated, suggest that the function of the liver cells difficult to last more than 1 weeks. The microencapsulated hepatocyte transplantation rats liver aminopherases, serum copper, liver copper levels were significantly lower than the naked hepatocyte transplantation group, 28 days before took on a declining trend, while the synthesis of albumin levels increased significantly, at the same time prolonging holding time effect. This comprehensive experimental results showed microencapsulated hepatocyte transplantation can improve copper metabolism level of HLD rats, alleviate the hepatic copper deposition, accelerate the serum copper metabolism, improve liver function, indicates that the research prospect in hepatocyte transplantation in the treatment of HLD. But HLD is a chronic disease, how to further improve the time to maintain the function of hepatocyte transplantation will be the next focus of research work.
